vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and COLLEGIUM PHARMACEUTICAL, INC (COLL). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $205.4M, roughly 1.2× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -35.0%, a 43.3% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -23.6%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $16.1M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
CCRN vs COLL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $205.4M |
| Net Profit | $-82.9M | $17.0M |
| Gross Margin | — | 62.5% |
| Operating Margin | -30.2% | 29.6% |
| Net Margin | -35.0% | 8.3% |
| Revenue YoY | -23.6% | 12.9% |
| Net Profit YoY | -2109.7% | 35.3% |
| EPS (diluted) | $-2.56 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $205.4M | ||
| Q3 25 | $250.1M | $209.4M | ||
| Q2 25 | $274.1M | $188.0M | ||
| Q1 25 | $293.4M | $177.8M | ||
| Q4 24 | $309.9M | $181.9M | ||
| Q3 24 | $315.1M | $159.3M | ||
| Q2 24 | $339.8M | $145.3M | ||
| Q1 24 | $379.2M | $144.9M |
| Q4 25 | $-82.9M | $17.0M | ||
| Q3 25 | $-4.8M | $31.5M | ||
| Q2 25 | $-6.7M | $12.0M | ||
| Q1 25 | $-490.0K | $2.4M | ||
| Q4 24 | $-3.8M | $12.5M | ||
| Q3 24 | $2.6M | $9.3M | ||
| Q2 24 | $-16.1M | $19.6M | ||
| Q1 24 | $2.7M | $27.7M |
| Q4 25 | — | 62.5% | ||
| Q3 25 | 20.4% | 61.7% | ||
| Q2 25 | 20.4% | 57.7% | ||
| Q1 25 | 20.0% | 54.8% | ||
| Q4 24 | — | 54.0% | ||
| Q3 24 | 20.4% | 60.8% | ||
| Q2 24 | 20.8% | 62.5% | ||
| Q1 24 | 20.4% | 63.1% |
| Q4 25 | -30.2% | 29.6% | ||
| Q3 25 | -2.4% | 29.7% | ||
| Q2 25 | -2.1% | 18.7% | ||
| Q1 25 | -0.3% | 12.2% | ||
| Q4 24 | -1.1% | 20.9% | ||
| Q3 24 | 0.9% | 21.9% | ||
| Q2 24 | -5.7% | 32.7% | ||
| Q1 24 | 0.8% | 34.1% |
| Q4 25 | -35.0% | 8.3% | ||
| Q3 25 | -1.9% | 15.0% | ||
| Q2 25 | -2.4% | 6.4% | ||
| Q1 25 | -0.2% | 1.4% | ||
| Q4 24 | -1.2% | 6.9% | ||
| Q3 24 | 0.8% | 5.9% | ||
| Q2 24 | -4.7% | 13.5% | ||
| Q1 24 | 0.7% | 19.1% |
| Q4 25 | $-2.56 | $0.48 | ||
| Q3 25 | $-0.15 | $0.84 | ||
| Q2 25 | $-0.20 | $0.34 | ||
| Q1 25 | $-0.02 | $0.07 | ||
| Q4 24 | $-0.13 | $0.36 | ||
| Q3 24 | $0.08 | $0.27 | ||
| Q2 24 | $-0.47 | $0.52 | ||
| Q1 24 | $0.08 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $386.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $301.7M |
| Total Assets | $449.0M | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $386.7M | ||
| Q3 25 | $99.1M | $285.9M | ||
| Q2 25 | $81.2M | $222.2M | ||
| Q1 25 | $80.7M | $197.8M | ||
| Q4 24 | $81.6M | $162.8M | ||
| Q3 24 | $64.0M | $120.0M | ||
| Q2 24 | $69.6M | $271.6M | ||
| Q1 24 | $5.2M | $318.0M |
| Q4 25 | $322.8M | $301.7M | ||
| Q3 25 | $408.1M | $274.8M | ||
| Q2 25 | $412.2M | $232.2M | ||
| Q1 25 | $418.2M | $234.4M | ||
| Q4 24 | $419.0M | $228.8M | ||
| Q3 24 | $424.7M | $234.3M | ||
| Q2 24 | $433.3M | $216.6M | ||
| Q1 24 | $462.4M | $222.2M |
| Q4 25 | $449.0M | $1.7B | ||
| Q3 25 | $538.2M | $1.6B | ||
| Q2 25 | $553.8M | $1.6B | ||
| Q1 25 | $576.2M | $1.6B | ||
| Q4 24 | $589.3M | $1.7B | ||
| Q3 24 | $597.4M | $1.6B | ||
| Q2 24 | $602.9M | $1.1B | ||
| Q1 24 | $648.4M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $123.0M |
| Free Cash FlowOCF − Capex | $16.1M | $122.4M |
| FCF MarginFCF / Revenue | 6.8% | 59.6% |
| Capex IntensityCapex / Revenue | 0.9% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 7.25× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $327.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $123.0M | ||
| Q3 25 | $20.1M | $78.4M | ||
| Q2 25 | $4.2M | $72.4M | ||
| Q1 25 | $5.7M | $55.4M | ||
| Q4 24 | $24.2M | $84.6M | ||
| Q3 24 | $7.5M | $-9.0M | ||
| Q2 24 | $82.4M | $67.4M | ||
| Q1 24 | $6.0M | $61.9M |
| Q4 25 | $16.1M | $122.4M | ||
| Q3 25 | $17.9M | $78.3M | ||
| Q2 25 | $2.3M | $72.4M | ||
| Q1 25 | $3.8M | $54.6M | ||
| Q4 24 | $21.7M | $84.1M | ||
| Q3 24 | $6.3M | $-9.2M | ||
| Q2 24 | $79.6M | $67.1M | ||
| Q1 24 | $3.8M | $61.4M |
| Q4 25 | 6.8% | 59.6% | ||
| Q3 25 | 7.2% | 37.4% | ||
| Q2 25 | 0.8% | 38.5% | ||
| Q1 25 | 1.3% | 30.7% | ||
| Q4 24 | 7.0% | 46.2% | ||
| Q3 24 | 2.0% | -5.8% | ||
| Q2 24 | 23.4% | 46.2% | ||
| Q1 24 | 1.0% | 42.3% |
| Q4 25 | 0.9% | 0.3% | ||
| Q3 25 | 0.9% | 0.1% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 0.6% | 0.4% | ||
| Q4 24 | 0.8% | 0.3% | ||
| Q3 24 | 0.4% | 0.2% | ||
| Q2 24 | 0.8% | 0.2% | ||
| Q1 24 | 0.6% | 0.4% |
| Q4 25 | — | 7.25× | ||
| Q3 25 | — | 2.49× | ||
| Q2 25 | — | 6.05× | ||
| Q1 25 | — | 22.92× | ||
| Q4 24 | — | 6.75× | ||
| Q3 24 | 2.92× | -0.96× | ||
| Q2 24 | — | 3.44× | ||
| Q1 24 | 2.23× | 2.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
COLL
Segment breakdown not available.
